MAPT and Alzheimer disease: Thus, drug candidates targeting the prevention of neural loss as well as the alleviation of Aβ aggregation and tau hyperphosphorylation would be promising therapeutic approach to treat AD (Hong‐Qi et al, 2012; Mondragon‐Rodriguez et al, 2012).